Author

A. L. Ellis-Connell

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Research Focus:host-pathogen & immune response· 4 Organism:non-human primate· 3 Assay:flow cytometry· 1 Organism:rat· 1

Frequent Co-Authors

A. J. Balgeman· 4 shared S. L. O'Connor· 4 shared A. M. Weiler· 3 shared O. E. Harwood· 3 shared R. V. Moriarty· 3 shared A. J. Weaver· 2 shared J. T. Safrit· 2 shared L. M. Matschke· 2 shared

Activity by Year

2022-2023 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersImmunology

A. J. Balgeman

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

CD8+ cells and small viral reservoirs facilitate post-ART control of SIV in Mauritian cynomolgus macaques

O. E. Harwood, L. M. Matschke, R. V. Moriarty, A. J. Balgeman, A. J. Weaver, A. L. Ellis-Connell, A. M. Weiler, L. C. Winchester, C. V. Fletcher, T. Friedrich, B. F. Keele, D. H. O'Connor, J. D. Lang, M. R. Reynolds, S. L. O'Connor

bioRxiv · Mar 1, 2023 · PreprintImmunology

Host Immunity to Mycobacterium tuberculosis Infection is Similar in Simian Immunodeficiency Virus (SIV)-infected, Antiretroviral Therapy-treated and SIV-naïve Juvenile Macaques

E. C. Larson, A. L. Ellis-Connell, M. Rodgers, A. K. Gubernat, J. L. Gleim, R. V. Moriarty, A. J. Balgeman, Y. K. Menezes, C. Ameel, D. J. Filmore, S. M. Pergalske, J. A. Juno, P. Maiello, A. G. White, H. J. Borish, , C. A. Scanga

This study compares host immunity to Mycobacterium tuberculosis in SIV-infected, ART-treated and SIV-naïve juvenile macaques, finding similar TB progression and T cell responses.

bioRxiv · Dec 14, 2022 · PreprintImmunology

Transient T cell expansion, activation, and proliferation in therapeutically vaccinated SIV+ macaques treated with N-803

O. E. Harwood, A. J. Balgeman, A. J. Weaver, A. L. Ellis-Connell, A. M. Weiler, K. N. Erickson, L. M. Matschke, A. E. Golfinos, V. Vezys, P. J. Skinner, J. T. Safrit, P. T. Edlefsen, M. R. Reynolds, T. C. Friedrich, S. L. O'Connor

This study shows that therapeutic vaccination with a heterologous prime-boost regimen followed by N-803 treatment enhances CD8+ T cell responses in SIV-infected macaques.

bioRxiv · Jul 8, 2022 · PreprintImmunology

Control of SIV infection in prophylactically vaccinated, ART-naïve macaques is required for the most efficacious CD8 T cell response during treatment with the IL-15 superagonist N-803

A. L. Ellis-Connell, A. J. Balgeman, O. E. Harwood, R. V. Moriarty, J. T. Safrit, A. M. Weiler, T. C. Friedrich, S. L. O'Connor

This study shows that N-803 treatment enhances CD8 T cell responses in SIV-infected macaques with low viral set-points, but not in those without prior immune control.

bioRxiv · Jun 2, 2022 · PreprintImmunology